Biogen Inc. Stock Rallies 5.0%, Outperforms Peers

Dow Jones
07/14

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Biogen Inc. rallied 5.0% to $209.03 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.8% to 7,515.34 and Dow Jones Industrial Average falling 0.3% to 52,498.64.

This was the stock's second consecutive day of gains.

Biogen Inc. closed 4.9% below its 52-week high of $219.72, which the company achieved on June 29th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.3% to $257.77, Pfizer Inc. rose 1.3% to $24.48, and AbbVie Inc. remained unchanged.

Trading volume totaled 2.3 million, compared to the 50-day average of 1.2 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 13, 2026 16:34 ET (20:34 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10